References
- Burkholder BM. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol. 2015;26(6):506–511. doi:10.1097/ICU.0000000000000206.
- Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(3):591–9, 9 e1. doi:10.1016/j.ophtha.2009.08.030.
- Lavezzo MM, Sakata VM, Morita C, et al. Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11:29.
- Herbort CP Jr. Abu El Asrar AM, Takeuchi M, et al. Catching the therapeutic window of opportunity in early initial-onset Vogt-Koyanagi-Harada uveitis can cure the disease. Int Ophthalmol. 2019;39(6):1419–1425. doi:10.1007/s10792-018-0949-4.
- Liu XY, Peng XY, Wang S, et al. Features of optical coherence tomography for the diagnosis of Vogt-Koyanagi-Harada Disease. Retina. 2016;36(11):2116–2123. doi:10.1097/IAE.0000000000001076.
- Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652. doi:10.1016/S0002-9394(01)00925-4.
- Lin D, Chen W, Zhang G, et al. Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy. BMC Ophthalmol. 2014;14:87. doi:10.1186/1471-2415-14-87.
- Yamamoto M, Nishijima K, Nakamura M, Yoshimura N. Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography. Jpn J Ophthalmol. 2011;55(1):1–6. doi:10.1007/s10384-010-0900-3.
- Rathinam SR, Namperumalsamy P, Nozik RA, Cunningham ET Jr. Vogt-Koyanagi-Harada syndrome after cutaneous injury. Ophthalmology. 1999;106(3):635–638. doi:10.1016/S0161-6420(99)90129-X.